35 lakh doses of J&J COVID-19 vaccine reach Kasuali lab
Date
9/15/2021 12:18:20 AM
(MENAFN- NewsBytes) Around 35 lakh doses of the COVID-19 vaccine developed by United States pharma giant Johnson & Johnson have reportedly reached the apex vaccine testing laboratory in Kasauli, Himachal Pradesh. The single-shot vaccine, called Janssen, has been found to be 85.4% against severe disease. India had approved the vaccine in August and it is being manufactured in collaboration with Hyderabad-based Biological E.
In this article
- Vaccine to be tested on 100 participants
Details Vaccine to be tested on 100 participants
An official of the Union Health Ministry told CNN-News18 that 35 lakh doses have been sent to the Kasauli lab in the first batch for testing. "It will take around two to three weeks for testing at CDL (Central Drugs Laboratory)," added the official. Thereafter, the COVID-19 vaccine will be tested on 100 participants for seven days in a fast-tracked model.
MENAFN15092021000165011035ID1102799054
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.